SR&ED Funding for Startups: How to Avoid Emergency Fundraising
The startup funding landscape is brutal. But what if there was a way to extend your runway without giving up equity or begging investors for a bridge round? The Challenge: A Familiar Startup Dilemma Imagine this: You’re a Canadian Fintech startup with a solid team, innovative product and a clear market opportunity. You’ve successfully raised […]
Grants vs Tax Credits: Which brings more cash flow?
When Canadian businesses need funding for growth, innovation or operational expenses, they often face a critical decision: Should they pursue government grants or focus on tax credits? Both funding mechanisms offer valuable financial support, but they impact your cash flow in fundamentally different ways. Understanding the timing, benefits and strategic implications of grants vs tax […]
CRIC : Quebec’s New Tax Credit Replaces SR&ED for Innovation
The introduction of the Research, Innovation, and Commercialization Tax Credit (CRIC) marks a major shift in Quebec’s landscape of tax incentives for innovation. Quebec replaces several existing measures related to SR&ED for corporate tax years beginning after March 25, 2025. This reform aims to boost innovation and strengthen the competitiveness of Quebec businesses. It also […]
IRAP Application Process: From Initial Contact to Funding Approval
While understanding what IRAP funding is provides the foundation, knowing how to navigate the application process is what separates successful applicants from those who miss out on this valuable opportunity. The IRAP application process can seem complex at first glance, but with the right guidance and preparation, it becomes a clear pathway to securing non-repayable […]
Financial Assistance in Canada: Strategies for Effective Overlap
In the competitive Canadian landscape of innovation and development, companies constantly seek incentives and funds for their research and development (R&D) activities. In this light, many turn to various sources of financial assistance, such as government grants, tax incentives, and private investments. Among these, the Canadian Scientific Research and Experimental Development (SR&ED) program stands out. […]
What’s changing in SR&ED review?
The Canada Revenue Agency (CRA) has updated its guidance on SR&ED review, specifically by expanding how it explains the review of both scientific work and associated expenditures. While this isn’t a change to the program itself, it reflects a clear expectation: businesses must be ready to demonstrate their claims clearly, consistently and with evidence. Here’s […]
Are you claiming all you can as a CCPC in Canada?
If you’re leading a Canadian company, you know your CCPC status isn’t just another technicality, it’s a strategic asset. From saving millions in taxes to leveraging generous federal and provincial incentives, the right classification can fuel growth and innovation. In this article, we’ll be explaining what CCPC is, why its status matters and how to […]
SR&ED Cannabis Eligibility: R&D Tax Credits in the Industry
Scientific Research and Experimental Development (SR&ED) program was established to support R&D and innovation in Canadian industry. Any Canadian company advancing its knowledge by overcoming uncertainties via systematic investigation is eligible for up to 65% refund for its R&D expenses, including salaries, subcontractors, and consumed materials. Almost any cannabis related company can be SR&ED eligible […]
SR&ED tax incentives for 3D printing Canadian businesses
In the realm of cutting-edge technology, 3D printing stands as a revolutionary force. It is transforming the way we design, manufacture, and innovate. This transformative technology has the potential to revolutionize industries from healthcare to aerospace. But its development and implementation require significant investment. Expenses include wages paid to engineers, technicians, and contractors, as well […]
SR&ED for Bioscience: Neurotechnology and Psychedelics
Over the last decade, Canada has been establishing itself a premier hub for innovative research in psychedelic research and neurotechnology, holding immense potential for revolutionizing mental health and neurological treatment. For emerging firms eager to make strides in the domain, navigating the financial landscape to fund such cutting-edge research can prove to be challenging. By […]